VSAR Versartis Inc.

$-100%

445,237 Shares Traded
550,696 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $3.12 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:27.17%
If Intiated One Month Ago, Shorts Have Realized a Return of:21.18%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.47%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.4%
Short Interest1.81 million
Float33.51 million
Short Ratio3.02
Market Cap$59.98 million
Market Maker ActivityDaily Short Volume

News

02-04-2018
BioSci Rounds Report For Feb. 2, 2018 (SeekingAlpha)
01-25-2018
Ascendis Pharma: The Rebound Purchase To End My Versartis Nightmare (SeekingAlpha)
12-22-2017
2017 YTD worst losers - healthcare (SeekingAlpha)
12-19-2017
Heading Into 2018 - With Cautious Optimism (SeekingAlpha)
12-19-2017
Biotech Forum Daily Digest: Spotlighting A Potential 'Razor & Razor Blade' Story (SeekingAlpha)
12-11-2017
Nasdaq Biotech Index: 54 to be added, 15 removed (SeekingAlpha)
12-08-2017
After Hours Gainers / Losers (SeekingAlpha)
12-07-2017
Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars (SeekingAlpha)
12-06-2017
Premarket Gainers as of 9:05 am (SeekingAlpha)
10-31-2017
Biggest Winners And Losers This Earnings Season (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 53.7%

Earnings Stats

PE Ratio -0.43
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $9.59
50 Day Moving Average $2
52 Week High $24
52 Week Low $1.6



Data provided for free by IEX. Questions? Read the FAQ